Gene therapy developer Renovacor, a Temple University spinout, has secured series A funding from investors including Novartis Venture Fund.
SnapGene, a molecular biology documentation spinout of UChicago, has been acquired by scientific data analysis tool provider GraphPad Software.
Indiana University's IURTC has become IU Ventures with a purview dedicated to administering the Philanthropic Venture Fund, angel network and entrepreneurial support services.
Osage University Partners is among the series B investors backing Virginia Tech-linked IBD therapy disease developer Landos Biopharma, which is preparing phase 2 trials.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
The spinout has revealed it added approximately $6m to a series A round backed by University of Pennsylvania and IP Group last year, bringing its total size to about $59m.